Blood Glucose
"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
| Descriptor ID |
D001786
|
| MeSH Number(s) |
D09.947.875.359.448.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 11 | 12 | | 1997 | 1 | 5 | 6 | | 1998 | 1 | 7 | 8 | | 1999 | 1 | 12 | 13 | | 2000 | 2 | 10 | 12 | | 2001 | 1 | 6 | 7 | | 2002 | 5 | 8 | 13 | | 2003 | 5 | 17 | 22 | | 2004 | 13 | 12 | 25 | | 2005 | 5 | 17 | 22 | | 2006 | 6 | 18 | 24 | | 2007 | 12 | 19 | 31 | | 2008 | 11 | 23 | 34 | | 2009 | 9 | 47 | 56 | | 2010 | 13 | 26 | 39 | | 2011 | 14 | 24 | 38 | | 2012 | 14 | 29 | 43 | | 2013 | 21 | 28 | 49 | | 2014 | 29 | 43 | 72 | | 2015 | 20 | 40 | 60 | | 2016 | 27 | 45 | 72 | | 2017 | 23 | 44 | 67 | | 2018 | 35 | 46 | 81 | | 2019 | 48 | 44 | 92 | | 2020 | 24 | 59 | 83 | | 2021 | 11 | 69 | 80 | | 2022 | 11 | 75 | 86 | | 2023 | 13 | 55 | 68 | | 2024 | 34 | 55 | 89 | | 2025 | 29 | 52 | 81 | | 2026 | 2 | 5 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
Chen NC, Shah VN, McQueen RB. Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence From Real-World Type 1 Diabetes Care. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1146-e1152.
-
Akturk HK, Karakus KE, Chen B, Walker TC. Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes. Diabetes Technol Ther. 2026 Mar; 28(3):264-270.
-
Moscoso-Vasquez M, Ekhlaspour L, Brown SA, DeBoer MD, Berget C, Cobry EC, Wadwa RP, Capodanno G, Cengiz E, Wong JC, Pryor EC, Villa-Tamayo MF, El Fathi A, Holmes V, Davis Prince S, Escobar E, Towers L, Hosseininpour Y, Narayan A, Koravi CLK, Nguyen T, Fulkerson D, Barnett CL, Oliveri MC, Breton MD, Forlenza GP. Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes. Diabetes Care. 2026 Mar 01; 49(3):401-409.
-
Montaser E, Williams C, Shah VN. Assessing Time Below Range as a Predictor of Severe Hypoglycemia: Insights From Six Clinical Trials. Diabetes Care. 2026 Mar 01; 49(3):483-489.
-
Nally LM, Sherr JL, Garg SK, Marks BE, Laffel LM, Pihoker C, Accacha SD, Thrasher JR, Abuzzahab MJ, Reed JH, Ekhlaspour L, Belapurkar S, Shulman DI, Sunil B, MacLeish SA, Latif K, Forlenza GP, Castorino K, Lal RA, Bode BW, Broyles FE, Carlson AL, Nwosu BU, Shin J, Ma H, Salbato A, Cordero TL, Treminio Y, McVean JJ, Rhinehart AS, Vigersky RA. Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor. Diabetes Technol Ther. 2026 Feb; 28(2):109-120.
-
Riddell MC, Parkin CG, Turner LV, Akturk HK. Potential Applications of Inhaled Insulin in Diabetic Ketoacidosis Prevention and During Exercise: Two Case Presentations. Diabetes Technol Ther. 2026 Feb; 28(1_suppl):31S-37S.
-
Karakus KE, Chesshir L, Walker S, Baschal EE, McDaniel KA, Triolo TM, Steck AK, Frohnert BI, Gottlieb PA, Michels AW, Simmons KM. Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes. Diabetologia. 2026 May; 69(5):1164-1175.
-
Jendle JH, Garg SK, Thivolet C, Weinstock RS, Hirsch IB, Evans M, Griffin KJ, Philis-Tsimikas A, Wheeler BJ, Kipnes MS, Carlson AL, Buckingham BA, Bhargava A, Bode BW, Lawson ML, Criego AB, McGill JB, Reed JCH, Prakasam G, Grunberger G, Girelli A, Martinez-Brocca MA, Christiansen MP, de Bock MI, Kudva YC, Lee SW, Yovanovich C, Shin JJ, Cordero TL, McVean JJF, Vigersky RA. Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial. Front Endocrinol (Lausanne). 2025; 16:1716587.
-
Benhalima K, Durnwald C, Sweeting A, Adams D, Addala A, Battelino T, Bergenstal RM, Carlson A, Donovan LE, Reis Franco D, Heverly J, Isaacs D, Khunti K, Kihara AB, Levitt N, Levy CJ, Lewer M, Mathiesen E, Murphy HR, Nishimura R, Polsky S, Ram U, Simmons D, Yamamoto JM, Tabák ÁG, Feig D, Scott EM. Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement. Lancet Diabetes Endocrinol. 2026 Feb; 14(2):157-177.
-
Patel BV, Wang SM, Messer LH, Pinsker JE, Polin MR, Hirsch IB, Ekhlaspour L, Edelman S, Brixner DI, Stemple C. HEDIS glycemic goal achieved using control-IQ Technology. Am J Manag Care. 2025 Dec 01; 31(12):e357-e363.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|